Baxter International Inc., a global innovator in renal care, and Mayo Clinic have announced a new collaboration to develop a renal care center of excellence in the United States. The center will serve patients across the continuum of renal care—from chronic kidney disease (CKD) management through transplant—and drive better patient outcomes.
 
The center is being established at the Mayo Clinic Dialysis Center at the campus in Jacksonville, Fla., where Mayo Clinic’s recognized excellence in care will be integrated with Baxter Renal Care Services’ proven clinical service model and CKD management program. The Mayo Clinic Dialysis Center in Jacksonville provides state-of-the-art dialysis services in a comfortable, home-like facility. The collaboration will also allow for the trial of potentially new, codeveloped products and services.
 
“The collaboration between Mayo Clinic and Baxter combines the best of our clinical, research and innovation expertise, and is rooted in the shared goal to improve the way we care for patients with serious and complex illnesses,” said Gianrico Farrugia, M.D., CEO of Mayo Clinic in Florida and president-elect of Mayo Clinic. “We are excited to establish this new renal care center of excellence with Baxter.”
 
For people with kidney disease or kidney failure requiring kidney dialysis, the Mayo Clinic Dialysis Center offers:
 

• Chronic Kidney Disease Clinic, where a dedicated team of providers work together to provide comprehensive care to people with kidney disorders
• Home dialysis training and support for both home hemodialysis and peritoneal dialysis
• In-center hemodialysis
• Outpatient dialysis services
• Nephrology Nutrition Clinic, where registered dieticians with expertise in kidney disorders provide ongoing guidance for nutritional needs
• Temporary dialysis if patients need treatment while traveling

 
Baxter Renal Care Services cares for more than 25,000 patients through its clinics across Asia, Europe and Latin America. Baxter Renal Care Services has historically worked closely with local experts to establish clinics where there is a need for centers of excellence that provide comprehensive care to help patients sequence through their therapy journey. These clinics often feature a successful CKD program focused on slowing the progression of kidney disease, as well as Baxter’s latest technologies to support patients’ clinical and lifestyle needs.
 
“We firmly believe there is a path to better care for kidney patients, which starts by managing the disease before dialysis is required and through simpler, more effective innovations,” said Laura Angelini, general manager of Baxter’s Renal Care business. “Our collaboration with Mayo Clinic will allow us to go even further in helping to establish transformative care.”
 
The dialysis clinic collaboration is the first launched initiative from the Baxter and Mayo Clinic five-year agreement announced in 2017, allowing the pair to bring together their respective clinical and development expertise. The primary emphasis of the broader agreement focuses on new research and development projects to advance innovation across different therapeutic areas where there are high unmet patient needs, such as renal disease. The initial agreement is for a five-year period, with a five-year renewal option.
 
Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing.
 
Every day, millions of patients and caregivers rely on Baxter’s portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, the company has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s heritage of medical breakthroughs to advance the next generation of healthcare innovations.